Tag: entrepreneurs
-
Experimental Drug Kills Myeloma Cells in Lab, Trial Planned
13 October 2014. Medical researchers at Imperial College London in the U.K. developed an experimental drug that in lab and animal tests kills multiple myeloma cancer cells without the toxic side effects of other cancer drugs. The team led by Imperial medical professor Guido Franzoso published its findings today in the journal Cancer Cell, with…
-
Company Launched for Tissue Regrowth, Inflammation Drugs
7 October 2014. Novare Pharmaceuticals, an enterprise commercializing research on a protein that can treat inflammatory diseases and help create new cells for rebuilding tissue, such as after a mastectomy, began operations today under the auspices of Allied Minds, a company creating start-ups based on scientific discoveries at U.S. universities and national labs. The new…
-
Investment Fund Launches to Support Stem Cell Ventures
29 September 2014. ReproCell Inc., a developer of stem cell lines for research and therapies in Yokohama, Japan, is starting an investment fund that aims to back new biotechnology companies bringing stem cell research to market. The fund, called Cell Innovation Partners, begins with ¥800 million ($US 7.3 million) in capital, provided by Shinsei Corporate…
-
Calico Licenses Neurodegenerative Disease Compounds
11 September 2014. California Life Company, better known as Calico, is licensing for development compounds shown to protect nerve cells in lab animals against degeneration and injury. Financial terms of the deal between Southwestern Medical Center and 2M Company in Dallas, with Calico, a one-year old company backed by Google, were not disclosed. A paper…
-
Patents, Start-Ups Increase in 2013 at U.S. University Labs
10 September 2014. The numbers of patents filed, licensing income, and start-ups generated by research at U.S. universities last year all increased, according to an annual survey conducted by the Association of University Technology Managers (AUTM), the organization of university staff responsible for research commercialization. The survey covers 202 responding institutions of 299 contacted, or…
-
Calico, AbbVie Partner on Aging Disorder Therapies
3 September 2014. California Life Sciences LLC, better known as Calico, and the pharmaceutical company AbbVie Inc. are collaborating on discovery and commercialization of drugs for age-related diseases such as cancer and neurodegenerative disorders. The partnership, which includes building a new research center, could result in a joint investment as high as $1.5 billion. Calico,…
-
Heart Assn Challenge Seeks Heart Disease Prevention Tools
11 August 2014. American Heart Association seeks new products to better prevent and manage heart disease and stroke in an open-innovation challenge for early-stage companies in the Midwest. The top three winners will be eligible for awards of up to $20,000, and a chance to pitch their ideas at a November forum on health care…
-
Licensing Deal Combines Genomics, Placenta Stem Cells
11 August 2014. A new licensing agreement will make available research by Celgene Cellular Therapeutics on stem cells from the placenta to Human Longevity Inc., a company specializing in genomics for age-related disorders. Financial aspects of the agreement were not disclosed, but as part of the deal, Celgene is expected to make an equity investment…
-
Trial Shows Stem Cell Treatment Feasibility for Stroke
8 August 2014. An early-stage clinical trial shows treating stroke patients with their own bone-marrow stem cells is safe and feasible, and provides evidence of improving cognitive and motor functions. The study conducted by Imperial College London and affiliated hospitals in the U.K. appears today in the journal Stem Cells Translational Medicine (registration required). The…
-
Graphene Sensor Designed for Wearable Disease Detection
7 August 2014. Engineers at University of Michigan in Ann Arbor designed a sensor from graphene that makes it possible to embed the technology into wearable devices for disease detection. The team from the labs of electrical engineering professor Zhaohui Zhong and biomedical engineering professor Sherman Fan published their results last month in the journal…